SETD2 and neoplasm: On the other hand, alterations in NOTCH1, CDKN2A, ARID2, EGFR, SETD2, PMS2, NTRK1, CCND1, and ATM were found in patients with non-responding tumors, but not in those with tumor size reductions (Figure 4).